Prevalence of allo-immunization anti-HLA and anti-integrin αIIbβ3 in Glanzmann Thromboasthenia patients

Haemophilia

Volumn 16, Issue 5, 2010, Pages 805-812

  Santoro, C ^a   Rago, A ^a   Biondo, F ^a   Conti, L ^b   Pulcinelli, F ^a   Laurenti, L ^a   Perrone, M P ^a   Baldacci, E ^a   Leporace, A ^a   Mazzucconi, M G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Allo immunization; Anti HLA anti integrin IIb 3 antibodies; Bleedings; Glanzmann Thromboasthenia; Platelet transfusions; Surgeries

Indexed keywords

ALPHA INTEGRIN; ALPHAIIBBETA3; HLA ANTIBODY; HLA ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLOIMMUNIZATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC SURGERY; EPISTAXIS; ERYTHROCYTE; FEMALE; FETUS WASTAGE; FRACTURE REDUCTION; GENE MUTATION; GLANZMANN DISEASE; HEMARTHROSIS; HEMATOTHORAX; HEMATURIA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYDROCELE; HYSTERECTOMY; LIVE BIRTH; LIVER BIOPSY; MALE; PREVALENCE; PRIORITY JOURNAL; SELECTIVE ABORTION; SURGICAL TECHNIQUE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; VAGINAL DELIVERY;

ADULT; AGED; DELIVERY, OBSTETRIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HLA ANTIGENS; HUMANS; INTEGRIN ALPHA2; INTEGRIN BETA3; ISOANTIBODIES; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET TRANSFUSION; PREGNANCY; THROMBASTHENIA; YOUNG ADULT;

EID: 77955980203     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02230.x     Document Type: Article

References (23)

1. Poon MC, D'Oiron R, Von Depka M. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2004, 2:1096-103.
2. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990, 75:1383-95.
3. Poon MC, d'Oiron R, Hann I. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 2001, 38(4 Suppl. 12):21-5.
4. Tengborn L, Petruson B. A patient with Glanzmann Thromboasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost 1996, 75:981-2.
5. Poon MC, Katsarou O, Huth-Kuehne A. Recombinant factor VIIa in congenital platelet bleeding disorders. Blood 2000, 96(Suppl. 1):256a. [Abstract]
6. D'Andrea G, Colaizzo D, Vecchione G, Grandone E, Di Minno G, Margaglione M. Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost 2002, 87:1034-42.
7. Poon MC, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999, 94:3951-3.
8. Almeida AM, Khair K, Hann I, Liesner R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003, 121:477-81.
9. Laursen B, Jacobsen SE, Taaning E, Grunnet N. Transfusion problems in patients with Glanzmann's thrombasthenia. Eur J Haematol 1992, 49:143-4.
10. Conte R, Cirillo D, Ricci F, Tassi C, Tazzari PL. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa. Haematologica 1997, 82:73-4.
11. Bellucci S, Damaj G, Boval B. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization. Bone Marrow Transplant 2000, 25:327-30.
12. Martin I, Kriaa F, Proulle V. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies. Br J Haematol 2002, 119:991-7.
13. Monte S, Lyons G. Peripartum management of a patient with Glanzmann's thrombasthenia using Thrombelastograph. Br J Anaesth 2002, 88:734-8.
14. Laurian Y, Tisseron-Maury B, Bibi Triki T, Kaplan C, Gaudelus J. Red blood cell transfusion in patients with type 1 Glanzmann's thrombasthenia. J Thromb Haemost 2005, 3:2346-7.
15. Leticee N, Kaplan C, Lemery D. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: is there a foetal risk? Eur J Obstet Gynecol Reprod Biol 2005, 121:139-42.
16. Connor P, Khair K, Liesner R. Stem cell transplantation for children with Glanzmann thrombasthenia. Br J Haematol 2008, 140:568-71.
17. Bellucci S, Caen J. Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment. Blood Rev 2002, 16:193-202.
18. Toogeh G, Sharifian R, Lak M, Safaee R, Artoni A, Peyvandi F. Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran. Am J Hematol 2004, 77:198-9.
19. Afrasiabi A, Artoni A, Karimi M, Peyvandi F, Ashouri E, Mannucci PM. Glanzmann thrombasthenia and Bernard-Soulier syndrome in south Iran. Clin Lab Haematol 2005, 27:324-7.
20. Nelson EJ, Nair SC, Peretz H. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients. J Thromb Haemost 2006, 4:1730-7.
21. Lak M, Scharling B, Blemings A. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram. Haemophilia 2008, 14:103-10.
22. Kannan M, Ahmad F, Yadav BK, Kumar R, Choudhry VP, Saxena R. Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann's thrombasthenia. J Thromb Haemost 2009, 7:1878-85.
23. Poon MC. The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders. Transfus Med Rev 2007, 21:223-36.